Article Information
History
- June 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Niels Adriaenssens1,†,*,
- Beatrice Scholtes2,†,
- Robin Bruyndonckx3,4,
- Jan Y Verbakel5,6,
- An De Sutter7,
- Stefan Heytens7,
- Ann Van den Bruel5,
- Isabelle Desombere8,
- Pierre Van Damme9,
- Herman Goossens4,
- Laëtitia Buret2,
- Els Duysburgh10,‡ and
- Samuel Coenen1,5,‡
- 1Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium
- 2Médecine Générale, Département des sciences cliniques, Université de Liège, Liège, Belgium
- 3Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Diepenbeek, Belgium
- 4Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium
- 5EPI-Centre, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
- 6Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
- 7Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
- 8Service Immune response, Department of Infectious Diseases in humans, Sciensano, Brussels, Belgium
- 9Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium
- 10Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium
- ↵*Corresponding author: Niels Adriaenssens, Gouverneur Kinsbergencentrum Doornstraat 331, BE-2610 Wilrijk Belgium, niels.adriaenssens{at}uantwerpen.be
Posted June 23, 2021.
Prevalence and Incidence of Antibodies Against Sars-Cov-2 Among Primary Healthcare Providers in Belgium During One Year of the Covid-19 Epidemic: Prospective Cohort Study Protocol
